与短信文本提醒器的相互作用与充血性心力衰竭患者改善药物坚持和再入院率相关:一项回顾性队列研究
Ben Long1, Brian Davis1, Rebekah McPheters1
1Department of Internal Medicine, Magnolia Regional Health Center, Corinth, Mississippi, United States of America.
PLOS digital health
|December 31, 2025
概括
短信服务 (SMS) 为心力衰竭患者提供了改进的处方补充. 这些文本提醒也减少了医院再入院,证明了它们在治疗慢性疾病中的价值.
科学领域:
- 医疗信息学 医疗信息学
- 患者的坚持 患者的坚持
- 心脏病学 心脏病学
背景情况:
- 短消息服务 (SMS) 文本提醒越来越多地用于改善弱势群体的药物坚持.
- 测量短信推送对处方填充率和医院再入院的影响是一个重大挑战.
研究的目的:
- 为了评估交互式短信推动在改善处方填充率方面的有效性.
- 评估短信推动对充血性心力衰竭 (CHF) 患者再入院率的影响.
主要方法:
- 在急诊室 (ED) 住院的充血性心力衰竭 (CHF) 患者的回顾性队列研究.
- 根据SMS互动与非互动的互动,匹配患者.
- 分析处方填充记录和随后的医院再接收数据.
主要成果:
- 与SMS推互动的患者显示,填写处方的几率增加了19% (OR 1.19,p < 0.001).
- 在与SMS推推互动的患者中,观察到重新入院的几率降低了6% (OR 0.94,p = 0.009).
结论:
- 交互式短信推动是有效提高处方填充率在不同的CHF患者群体.
- 这种新型的SMS推动工具显示了降低CHF患者再入院的潜力.
相关概念视频
Heart Failure VI: Adjunct Therapies
233
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
233
Heart Failure V: Medical Management
196
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
196
Acute Coronary Syndrome IV: Interprofessional Care
197
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
874
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
874
Mitral Regurgitation IV: Nursing Management
286
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
286
Errors occurring during blood pressure monitoring
1.3K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
1.3K


